(0.11%) 5 252.25 points
(0.05%) 39 662 points
(0.22%) 18 295 points
(0.35%) $78.53
(1.20%) $2.28
(-1.16%) $2 347.40
(-0.48%) $28.37
(0.20%) $1 009.20
(-0.09%) $0.927
(0.18%) $10.85
(-0.03%) $0.798
(-1.26%) $91.51
Live Chart Being Loaded With Signals
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need...
Stats | |
---|---|
Today's Volume | 126 682 |
Average Volume | 243 451 |
Market Cap | 53.94M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.0900 ) 2024-05-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.03 |
ATR14 | $0.0190 (1.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Tom Penny | Sell | 0 | Common Stock |
2024-03-06 | Tom Penny | Sell | 45 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 40 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 60 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 40 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
61.34 |
Last 97 transactions |
Buy: 3 858 069 | Sell: 577 250 |
Volume Correlation
Equillium Inc Correlation
10 Most Positive Correlations | |
---|---|
PXLW | 0.95 |
PEPG | 0.944 |
POWL | 0.944 |
COHR | 0.931 |
FWRG | 0.928 |
CFLT | 0.922 |
KTCC | 0.921 |
GRNV | 0.919 |
ALLO | 0.919 |
KYMR | 0.917 |
10 Most Negative Correlations | |
---|---|
AMRB | -0.94 |
LSTR | -0.939 |
RMBS | -0.937 |
LSCC | -0.936 |
MCHP | -0.932 |
KE | -0.93 |
SNSR | -0.926 |
GRID | -0.917 |
PWP | -0.916 |
INSE | -0.913 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Equillium Inc Correlation - Currency/Commodity
Equillium Inc Financials
Annual | 2023 |
Revenue: | $36.08M |
Gross Profit: | $35.96M (99.65 %) |
EPS: | $-0.380 |
FY | 2023 |
Revenue: | $36.08M |
Gross Profit: | $35.96M (99.65 %) |
EPS: | $-0.380 |
FY | 2022 |
Revenue: | $15.76M |
Gross Profit: | $15.64M (99.25 %) |
EPS: | $-3.19 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.579 |
Financial Reports:
No articles found.
Equillium Inc
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators